INS and Hypoglycemia: Insulin analogues have been shown to reduce glucose variability, improve glucose control, enhance quality of life, reduce emergency department visits or hospital admission due to severe hypoglycaemia and reduce the overall reduce risk of hypoglycaemia, especially nocturnally, compared with intermediate-acting human insulins [132,133,134,135].